eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Kidney, Kidney (Renal Cell) Cancer: Click to Expand ⟱
Kidney (Renal Cell) Cancer
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Kidney, |
Caki-1 |
|
|
|
ER Stress↑, p‑eIF2α↑, XBP-1↑, GRP78/BiP↑, CHOP/DDIT3↑, eff↓,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Kidney, |
786-O |
|
|
|
- |
in-vitro, |
BC, |
SkBr3 |
|
|
|
ROS↑, TumCP↓, Apoptosis↑, eff↓, Sp1/3/4↓, cycD1/CCND1↓, survivin↓, cMyc↓, EGFR↓, cMET↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, survivin↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Sp1/3/4↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, p‑eIF2α↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1, XBP-1↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
cMET↓, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 2,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:12 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page